✦ LIBER ✦

Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agents

✍ Scribed by Agnieszka Michael; Kate Relph; Hardev Pandha

Publisher: John Wiley and Sons
Year: 2010
Tongue: French
Weight: 190 KB
Volume: 127
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.25389

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Anti‐angiogenic agents targeting tumour vasculature have an established place in clinical practice, and new data are constantly emerging. However, despite rapid clinical uptake, a very large number of questions regarding these agents remain unanswered. One of the main hurdles in clinical practice is lack of accurate and feasible ways of assessing response to drug beyond tumour reduction on conventional imaging. This review summarises recent developments in the field of biomarkers of response to anti‐VEGF drugs.

📜 SIMILAR VOLUMES

Potentiation of cytotoxic cancer therapi

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

✍ Beverly A. Teicher; Sylvia A. Holden; Gulshan Ara; Enrique Alvarez Sotomayor; Zh 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 724 KB

Targeted radionuclide therapy of melanom

Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new 131I labelled potential agent

✍ Mathilde Bonnet-Duquennoy; Janine Papon; Florence Mishellany; Pierre Labarre; Je 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 497 KB

## Abstract In recent years, there has been dramatic worldwide increase in incidence of malignant melanoma. Although localised disease is often curable by surgical excision, metastatic melanoma is inherently resistant to most treatments. In this context, targeted radionuclide therapy could be an ef

Influence of an anti-angiogenic treatmen

Influence of an anti-angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy

✍ Beverly A. Teicher; Sylvia A. Holden; Gulshan Ara; Norman P. Dupuis; Fang Liu; J 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 717 KB

Control of Monocyte Morphology on and Re

Control of Monocyte Morphology on and Response to Model Surfaces for Implants Equipped with Anti-Inflammatory Agent

✍ N. Benkirane-Jessel; P. Lavalle; F. Meyer; F. Audouin; B. Frisch; P. Schaaf; J. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 2 views

ChemInform Abstract: A Synthesis Strateg

ChemInform Abstract: A Synthesis Strategy to a New Class of Cycloalkane Ring-Fused Pyridine Nucleosides as Potential Anti-HIV Agents.

✍ G. E. H. ELGEMEIE; A. M. E. ATTIA; B. A. W. HUSSAIN 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt